Evaluate gastrointestinal, pancreatic, and hepatobiliary cancers in the context of up-to-date grading and staging guidelines.
Evaluate difficult GI lesions with a better understanding of the relevant histologic features of those lesions, as well as the techniques that add value in their assessment.
Evaluate non-tumoral pathology of the GI tract and liver with a better understanding of the differential diagnosis, how to incorporate clinical information into that differential, and how to address the needs of clinical colleagues
The course is designed to update both academic practicing pathologists and those in the community with advances in gastrointestinal, pancreatic, and hepatobiliary pathology, and to provide aids in diagnosis based on conventional morphologic analysis, as well as updates on new staging criteria, new techniques such as novel immunohistochemistry markers, and molecular pathology data. Interactive learning formats, including didactic lectures, case seminars, and frequent discussion periods with extensive time for contact with faculty will be provided. The course will assist the learners in developing new strategies they can use in practice, leading to improved diagnoses, and better patient care.
This accredited course is offered by Mass General Hospital. This course is targeted to Specialty Physicians and Allied Health Professionals. Contact ceprograms@hms.harvard.edu with questions.
